Cardiotoxicity with doxorubicin, trastuzumab, and development of the metabolic syndrome: Case report. RSD [Internet]. 2021 May 13 [cited 2025 Dec. 6];10(5):e46910515037. Available from: https://rsdjournal.org/rsd/article/view/15037